The Role of FAM19A4 and Hsa-mir-124 Methylation in Predicting Prognosis of Untreated Cervical Intraepithelial Neoplasia 2 (CIN 2)
Condition(s):Cervical Intraepithelial Neoplasia Grade 2; DNA MethylationLast Updated:November 22, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Cervical Intraepithelial Neoplasia Grade 2; DNA MethylationLast Updated:November 22, 2022Recruiting
Condition(s):HPV Infection; Cervical CancerLast Updated:December 7, 2023Recruiting
Condition(s):CIN2Last Updated:September 28, 2023Completed
Condition(s):Cervical Intraepithelial Neoplasia Grade 2/3; RecurrenceLast Updated:February 15, 2024Not yet recruiting
Condition(s):Cervical Intraepithelial Neoplasia Grade 2 (CIN2)Last Updated:December 7, 2023Active, not recruiting
Condition(s):CIN2; TherapyLast Updated:October 26, 2022Completed
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:January 11, 2010Completed
Condition(s):HPV16 Positive; Cervical Intraepithelial Neoplasia (CIN 2/3)Last Updated:July 9, 2018Completed
Condition(s):Cervical Intraepithelial Neoplasia; Cervical DysplasiaLast Updated:September 7, 2023Completed
Condition(s):HIV-1 InfectionLast Updated:May 11, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.